Spatial and Temporal Analysis of Meningitis Cumulative Incidence in Iran, 2011-2022
Abstract
Background: Meningitis is a public health challenge and one of the plans of the WHO is to defeat meningitis by 2030. This study was conducted to determine the trend of cumulative incidence and to draw a geographic map of meningitis in Iran.
Methods: Data on the cases of Fever and Neurological Symptoms Syndrome was obtained from the national surveillance system from 2011 to 2022. The cumulative incidence of meningitis was calculated for each year. Joinpoint version 5.4.0 and ArcGIS Desktop (ArcMap) 10.8.2 were used to investigate the trend of the disease incidence and identify the high-risk areas, respectively.
Results: Overall, 18,500 (24.35%) of the total cases were reported as confirmed and probable cases of meningitis. The cumulative incidence of bacterial meningitis decreased significantly in all age groups (P<0.05). The incidence of viral meningitis decreased in all ages and the population under 5 years (P<0.05). The incidence of Hib meningitis decreased in the population under 5 yr from 2015-2019 (P<0.05). The incidence of meningitis from all forms decreased in all ages and populations under 5 yr but increased in the population over 5 yr from 2011 to 2019, though these changes were not statistically significant.
Conclusion: The incidence of bacterial and viral meningitis has decreased in Iran similar to most parts of the world. The decrease in the incidence of Hib meningitis after the implementation of the vaccination in children under 5 yr emphasizes the importance of continuing Hib vaccination and integrating pneumococcal and meningococcal vaccinations into the national vaccination program.
1. Zbrzeźniak J, Paradowska-Stankiewicz I (2019). Meningitis and encephalitis in Poland in 2017. Przegl Epidemiol, 73(4):417-427.
2. Terwin K, Ferreira M, Minnie C, et al (2022). The epidemiological profile of meningitis among adults in a South African district hospital. Pan Afr Med J, 41: 256.
3. Karami M, Ghalandari M, Poorolajal J, et al (2017). Early detection of meningitis outbreaks: Application of limited-baseline data. Iran J Public Health, 46 (10):1366-1373.
4. Loutfi A, Jayche S, Mohammed L, et al (2020). Epidemiological, Cytochemical and Bacteriological Profile of Meningitis among Adults and Children in North West of Morocco. Pak J Biol Sci, 23 (7):891-897.
5. Ocampo FF, Espiritu AI, Jamora RDG (2022). Current status and challenges in the care of patients with bacterial meningitis in the Philippines: A scoping review. Trop Med Int Health, 27 (1):38-48.
6. Boni-Cisse C, Jarju S, Bancroft RE, et al (2019). Etiology of bacterial meningitis among children< 5 years old in Côte d’Ivoire: findings of hospital-based surveillance before and after pneumococcal conjugate vaccine introduction. Clin Infect Dis, 69(Suppl 2):S114-S120.
7. Hasbun R (2022). Progress and Challenges in Bacterial Meningitis: A Review. JAMA, 328 (21):2147-2154.
8. Berangi Z, Karami M, Mohammadi Y, et al (2019). Epidemiological profile of meningitis in Iran before pentavalent vaccine introduction. BMC Pediatr, 19:370.
9. Schiess N, Groce NE, Dua T (2021). The impact and burden of neurological sequelae following bacterial meningitis: A narrative review. Microorganisms, 9 (5):900.
10. Gahlot T, Kasana D (2021). A cross-sectional study of etiological and sensitivity profiling of meningitis in under-five children. Int J Mycobacteriol, 10 (2):149-154.
11. Saraiva MdGG, Santos ECS, Saraceni V, et al (2015). Epidemiology of infectious meningitis in the State of Amazonas, Brazil. Rev Soc Bras Med Trop, 48 Suppl 1:79-86.
12. Houri H, Pormohammad A, Riahi SM, et al (2017). Acute bacterial meningitis in Iran: Systematic review and meta-analysis. PLoS One, 12 (2): e0169617.
13. Meiring S, Cohen C, de Gouveia L, et al (2022). Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020. Int J Infect Dis, 122:1056-1066.
14. Wang Y, Huang X, Yue S, et al (2022). Secular Trends in the Incidence of Migraine in China from 1990 to 2019: A Joinpoint and Age–Period–Cohort Analysis. J Pain Res, 15:137-146.
15. Moradi G, Zahraei SM, Khazaei Z, et al (2021). Epidemiology incidence and geographical distribution of Meningitis using GIS and its incidence prediction in Iran in 2021. Med J Islam Repub Iran, 35:110.
16. Heidari S, Karami M, Zahraei SM, et al (2021). Epidemiological profile of meningitis following pentavalent vaccination in Iran: impact of vaccine introduction. J Epidemiol Glob Health, 11 (3):310-315.
17. Truong HC, Van Phan T, Nguyen HT, et al (2023). Childhood Bacterial Meningitis Surveillance in Southern Vietnam: Trends and Vaccination Implications from 2012 to 2021. Open Forum Infect Dis, 10(7):ofad229.
18. Polkowska A, Toropainen M, Ollgren J, et al (2017). Bacterial meningitis in Finland, 1995–2014: a population-based observational study. BMJ Open, 7 (5):e015080.
19. Wong CH, Duque JR, Wong JSC, et al (2021). Epidemiology and trends of infective meningitis in neonates and infants less than 3 months old in Hong Kong. Int J Infect Dis, 111:288-294.
20. Chicuto LAD, de Moraes C, Cássio de Moraes J, et al (2020). A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): Implications for public health decisions. Hum Vaccin Immunother, 16 (8):1945-1950.
21. Pérez AE, Dickinson FO, Rodríguez M (2010). Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infect Dis, 10:130.
22. Parellada CI, Abreu AdJLd, Birck MG, et al (2023). Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019. Vaccines (Basel), 11 (8):1279.
23. Jesri N, Rezaei F, Saghafipour A, et al (2016). Spatial analysis of bacterial meningitis in Iran using geographical information system. J Mazandaran Univ Med Sci, 25 (132):309-314.
| Files | ||
| Issue | Vol 54 No 11 (2025) | |
| Section | Original Article(s) | |
| Keywords | ||
| Incidence Meningitis Bacterial Haemophilus Viral Spatio-temporal analysis Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |



